Literature DB >> 30101523

Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis.

M Chen1, C Quan1, L Diao1, F Xue1, K Xue1, B Wang1, X Li1, X Zhu2, J Zheng1, H Cao1.   

Abstract

BACKGROUND: Dermatomyositis (DM) is an autoimmune disease affecting primarily the skin, muscle and lung. Dysregulations of cytokines and chemokines are commonly found in inflammatory disorders.
OBJECTIVES: To investigate the association between serum cytokines and chemokines and clinical severity, especially cutaneous lesions and interstitial lung disease (ILD) in patients with DM and clinically amyopathic DM (CADM).
METHODS: Clinical features, laboratory findings and serum of 40 patients with DM or CADM were collected and analysed. Serum cytokines and chemokines were measured by enzyme-linked immunosorbent assay or cytometric bead array. A multiple unpaired t-test was performed to compare cytokines and chemokines in patients with DM and healthy controls. Correlations of serum cytokines and chemokines with disease severity were evaluated by Spearman's rank correlation test.
RESULTS: Serum interferon (IFN)-β [rs  = 0·37, 95% confidence interval (CI) 0·078-0·62; P = 0·019] and CXCL10 (rs  = 0·32, 95% CI to -0·004 to 0·57; P = 0·045) were significantly correlated with the Cutaneous Dermatomyositis Disease Area and Severity Index activity score in the subset of patients with DM or CADM. Serum levels of interleukin (IL)-6, IL-10, IL-18 and IFN-β were significantly higher in the patients with acute/subacute interstitial pneumonia (A/SIP) than in the subset without A/SIP (P < 0·05). IL-6 (rs  = 0·54, 95% CI 0·27-0·72; P < 0·001) and IL-18 (rs  = 0·46, 95% CI 0·21-0·65; P = 0·003) were significantly correlated with the serum level of anti-melanoma differentiation-associated protein 5 antibody.
CONCLUSIONS: Serum levels of IFN-β and CXCL10 may be useful biomarkers for assessing cutaneous disease activity in patients with DM and CADM. In addition, serum IL-6, IL-10, IL-18 and IFN-β were highly correlated with the occurrence of A/SIP. These cytokines may play a role in the pathogenesis of DM and CADM.
© 2018 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30101523     DOI: 10.1111/bjd.17079

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  15 in total

Review 1.  Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.

Authors:  Wanlong Wu; Li Guo; Yakai Fu; Kaiwen Wang; Danting Zhang; Wenwen Xu; Zhiwei Chen; Shuang Ye
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-06       Impact factor: 8.667

Review 2.  The validity and utility of the Cutaneous Disease Area and Severity Index (CDASI) as a clinical outcome instrument in dermatomyositis: A comprehensive review.

Authors:  S Ahmed; K L Chen; V P Werth
Journal:  Semin Arthritis Rheum       Date:  2020-01-11       Impact factor: 5.532

Review 3.  Update on Biomarkers of Vasculopathy in Juvenile and Adult Myositis.

Authors:  Kirsty McLellan; Charalampia Papadopoulou
Journal:  Curr Rheumatol Rep       Date:  2022-06-10       Impact factor: 4.686

4.  A New Predictive Model for the Prognosis of MDA5+ DM-ILD.

Authors:  Qian Niu; Li-Qin Zhao; Wan-Li Ma; Liang Xiong; Xiao-Rong Wang; Xin-Liang He; Fan Yu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

5.  Hierarchical cluster analysis of cytokine profiles reveals a cutaneous vasculitis-associated subgroup in dermatomyositis.

Authors:  Jingjing Bai; Chanyuan Wu; Danli Zhong; Dong Xu; Qian Wang; Xiaofeng Zeng
Journal:  Clin Rheumatol       Date:  2020-08-14       Impact factor: 2.980

6.  Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients.

Authors:  Julie J Paik; Livia Casciola-Rosen; Joseph Yusup Shin; Jemima Albayda; Eleni Tiniakou; Doris G Leung; Laura Gutierrez-Alamillo; Jamie Perin; Liliana Florea; Corina Antonescu; Sherry G Leung; Grazyna Purwin; Andrew Koenig; Lisa Christopher-Stine
Journal:  Arthritis Rheumatol       Date:  2021-03-24       Impact factor: 10.995

7.  Myeloid Dendritic Cells Are Major Producers of IFN-β in Dermatomyositis and May Contribute to Hydroxychloroquine Refractoriness.

Authors:  Kristen L Chen; Jay Patel; Majid Zeidi; Maria Wysocka; Muhammad M Bashir; Basil Patel; Spandana Maddukuri; Barbara White; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2021-03-04       Impact factor: 7.590

8.  Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM.

Authors:  Spandana Maddukuri; Jay Patel; De Anna Diaz; Kristen L Chen; Maria Wysocka; Christina Bax; Yubin Li; Adarsh Ravishankar; Madison Grinnell; Majid Zeidi; Nithin Reddy; Josef Symon S Concha; Muhammad M Bashir; Joyce Okawa; Barbara White; Victoria P Werth
Journal:  Arthritis Res Ther       Date:  2022-01-04       Impact factor: 5.606

9.  Transcriptome Sequencing Identifies PLAUR as an Important Player in Patients With Dermatomyositis-Associated Interstitial Lung Disease.

Authors:  Juan Chen; Ruixian Zhang; Min Xie; Chunyan Luan; Xiaolan Li
Journal:  Front Genet       Date:  2021-12-06       Impact factor: 4.599

10.  IL18-containing 5-gene signature distinguishes histologically identical dermatomyositis and lupus erythematosus skin lesions.

Authors:  Lam C Tsoi; Mehrnaz Gharaee-Kermani; Celine C Berthier; Tori Nault; Grace A Hile; Shannon N Estadt; Matthew T Patrick; Rachael Wasikowski; Allison C Billi; Lori Lowe; Tamra J Reed; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  JCI Insight       Date:  2020-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.